Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience

Am J Hematol. 2019 May;94(5):E127-E129. doi: 10.1002/ajh.25432. Epub 2019 Feb 21.

Authors

Nivedita Arora¹, Corbin Eule¹, Arjun Gupta¹, Hsiao C Li^{2

3}, Navid Sadeghi^{2

3}

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
² Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
³ Division of Hematology and Oncology, Parkland Health and Hospital System.

PMID: 30734351
DOI: 10.1002/ajh.25432

No abstract available

Publication types

Clinical Trial
Letter
Multicenter Study

MeSH terms

Adult
Aged
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Middle Aged
Plasmablastic Lymphoma* / blood
Plasmablastic Lymphoma* / mortality
Plasmablastic Lymphoma* / pathology
Plasmablastic Lymphoma* / therapy
Survival Rate